Apple says it will begin selling Apple Watch Series 9 and Ultra 2 without the blood oxygen feature tomorrow
Earlier today, a US appeals court rejected Apple’s request to pause the Apple Watch Series 9 and Ultra 2 ban as the company appeals an ITC ruling that the Apple Watch blood oxygen sensor infringes on two patents held by medical device company Masimo.
Under this decision, Apple will be barred from selling the Apple Watch Series 9 and Ultra 2 with pulse oximetry features starting tomorrow, January 18 at 5 p.m. ET.
Apple, however, has a plan. The company tells 9to5Mac that it will begin selling the Apple Watch Series 9 and Ultra 2 in the United States without the blood oxygen feature tomorrow.
